JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating
Business
Archived
•
November 17, 2025
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Output is a realization of Input."